|
(P1962) |
Patient-specific induced pluripotent stem cells and derived cardiomyocytes as an in vitro screening platform for the discovery of new therapeutic options for Fabry disease. |
| |
|
C. Jahn, T. Thum, C. Bär, J. Hoepfner, M. Juchem (Hannover) |
|
(P1963) |
Autologous pericardium for aortic valve replacement – associated leaflet tissue and ECM properties in comparison to bovine pericardial patches |
| |
|
C. Dittfeld, S. Bähring, K. Alexiou, C. Welzel, D. Salminger, A. Jannasch, K. Matschke, S. M. Tugtekin (Dresden) |
|
(P1964) |
Minimalinvasive off-pump Platzierung und Funktionsweise eines intraperikardialen, biventrikulären Herzunterstützungssystemes |
| |
|
U. Stock, C. Bowles, R. Hinkel, H. De Vaal, S. M. Wildhirt, S. Schüler (Harefield, Newcastle, UK; Göttingen, München) |
|
(P1965) |
In vivo evaluation of immunomodulated hearts in a heterotopic abdominal heart transplantation model in the pig |
| |
|
A. Bähr, S. Michel, N. Hornaschewitz, L. Oberberger, N. Klymiuk, B. Reichart, C. Kupatt (München) |
|
(P1966) |
Generation of mouse models with genetic modifications for cardiovascular research using a fast and precise CRIPSR-based knock-in technology |
| |
|
R. Medert, M. Freichel (Heidelberg) |
|
(P1967) |
Evaluation of miRNA-based therapies targeting ACE2/TMPRSS2 in ex vivo living myocardial slices (LMS) |
| |
|
J. Weusthoff, K. Xiao, M. Fuchs, A. Just, A. Pfanne, T. Thum, J. Fiedler (Hannover) |